| ID: | 174 | |
|---|---|---|
| Name: | Compound 174 | |
| Description: | Original numeration in publication: 14 | |
| Labels: | Training_set, Thiazolidine-2, 4-dione | |
| CAS: | ||
| InChi Code: | InChI=1S/C22H19Cl2N3O4S/c1-2-9-25-20(29)13-4-7-16(8-5-13)26-19(28)12-27-21(30)18(32-22(27)31)10-14-3-6-15(23)11-17(14)24/h3-8,10-11H,2,9,12H2,1H3,(H,25,29)(H,26,28)/b18-10- |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.66 |
El-Adl, K.; El-Helby, A.-G. A.; Sakr, H. a. A., R. R.; Mahdy, H. A.; Nasser, M. a. A., H. S.; El-Hddad, S. S. A. Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2021, 354, e2000279. https://doi.org/10.1002/ardp.202000279 |
| 6.3386 |
Eq1: VEGFR-2 inhibition (Data used to train model) |